Clinical Trials
Our department has been recognized as one of the nodal centre for vaccine trials. Various trials are ongoing in various stages.
- Effect of Maternal diet on acceptance of complementary feeds in the infants.
- WHO Global Vaccine Safety Multi Country collaboration.
- A phase II/III, multicentre, randomized, open label, active controlled, clinical study to assess the immunogenicity and safety of tetanus toxoid, diphtheria toxoid, and acellular pertussis (Tdap) vaccine manufactured by Serum institute of India Pvt. Ltd. (SIIPL) in comparison with Boostrix® vaccine of GSK in healthy adults, adolescents and children in India.
- Safety and Immunogenicity of booster dose of a Hexavalent Vaccine SHAN6TM (DTwP-HepB-Hib-IPV) with or without co-administration of MMR vaccine in Toddlers
- Immune Lot-to-Lot Consistency and Non-Inferiority of SHAN6TMvaccine in Comparison to SHAN 5® + SHANIPV™ When Administered as Three Doses at 6-8, 10-12 and 14-16 weeks of age in Healthy Indian Infants, Concomitantly with Oral Rotavirus Vaccine